Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
- PMID: 37234711
- PMCID: PMC10206212
- DOI: 10.3389/fphar.2023.1154167
Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
Abstract
Heart failure with preserved ejection fraction accounts for a large proportion of heart failure, and it is closely related to a high hospitalization rate and high mortality rate of cardiovascular disease. Although the methods and means of modern medical treatment of HFpEF are becoming increasingly abundant, they still cannot fully meet the clinical needs of HFpEF patients. Traditional Chinese medicine is an important complementary strategy for the treatment of diseases in modern medicine, and it has been widely used in clinical research on HFpEF in recent years. This article reviews the current situation of HFpEF management, the evolution of guidelines, the clinical evidence and the mechanism of TCM in the treatment of HFpEF. The purpose of this study is to explore the application of TCM for HFpEF, to further improve the clinical symptoms and prognosis of patients and to provide a reference for the diagnosis and treatment of the disease.
Keywords: cardiovascular disease; clinical evidence; heart failure with preserved ejection fraction; potential mechanisms; traditional Chinese medicine.
Copyright © 2023 Fan, Yang, Wang, Liu, Song, Liu, Wang, Zhao and Mao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Treatment of Heart Failure with Preserved Ejection Fraction.Adv Exp Med Biol. 2018;1067:67-87. doi: 10.1007/5584_2018_149. Adv Exp Med Biol. 2018. PMID: 29498023 Review.
-
Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.ESC Heart Fail. 2022 Aug;9(4):2336-2347. doi: 10.1002/ehf2.13921. Epub 2022 Apr 18. ESC Heart Fail. 2022. PMID: 35437939 Free PMC article.
-
Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology.Korean Circ J. 2020 Dec;50(12):1051-1061. doi: 10.4070/kcj.2020.0338. Epub 2020 Sep 15. Korean Circ J. 2020. PMID: 33150751 Free PMC article. Review.
-
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30. J Am Coll Cardiol. 2014. PMID: 24184245 Free PMC article. Clinical Trial.
-
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31744275 Chinese.
Cited by
-
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.Front Cardiovasc Med. 2025 Apr 29;12:1514181. doi: 10.3389/fcvm.2025.1514181. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40364827 Free PMC article.
-
Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.Front Cardiovasc Med. 2023 Nov 20;10:1255940. doi: 10.3389/fcvm.2023.1255940. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38054101 Free PMC article. Review.
-
Active ingredients of traditional Chinese medicine inhibit NOD-like receptor protein 3 inflammasome: a novel strategy for preventing and treating heart failure.Front Immunol. 2025 Jan 24;16:1520482. doi: 10.3389/fimmu.2025.1520482. eCollection 2025. Front Immunol. 2025. PMID: 39925805 Free PMC article. Review.
-
Systematic Review of Preclinical Studies on the Efficacy and Mechanisms of Herbal Medicines in Post-Myocardial Infarction Heart Failure with Reduced Ejection Fraction.Medicina (Kaunas). 2024 Jul 5;60(7):1101. doi: 10.3390/medicina60071101. Medicina (Kaunas). 2024. PMID: 39064530 Free PMC article.
-
Vitamin D and Cardiovascular Diseases: An Update.Cureus. 2023 Nov 30;15(11):e49734. doi: 10.7759/cureus.49734. eCollection 2023 Nov. Cureus. 2023. PMID: 38161941 Free PMC article. Review.
References
-
- Bai Z. X. (2022). Clinical study on Qifu Qiangxin decoction in the treatment of Heart Yang deficiency, blood stasis and fluid retention syndrome of heart failure with preserved ejection fraction. Changsha: Hunan University of Chinese Medicine.
-
- Chen C., Zhang W. S., Yang Y. H., Chen L., Li X. (2022). Clinical efficacy observation of Jianxin granule on elderly heart failure with preserved ejection fraction of qi deficiency and blood stasis type. Shanxi J. Traditional Chin. Med. 38 (01), 16–19. 10.20002/j.issn.1000-7156.2022.01.006 - DOI
-
- Chen H. (2018). Study on the clinical efficacy of Shuxin decoction in the treatment of heart failure with preserved ejection fraction. Hefei: Anhui University of Chinese Medicine.
Publication types
LinkOut - more resources
Full Text Sources